News

Johnson & Johnson: Raising My Price Target Amid Stable EPS Growth
Johnson & Johnson's recent earnings beat expectations, with strong Medicine and MedTech growth. Read why I have a buy rating ...
The American Journal of Managed Care4d
Guselkumab Demonstrates Rapid and Lasting Results in Crohn Disease
Guselkumab shows significant clinical and endoscopic benefits for adults with moderate to severe Crohn disease, offering a ...
Zacks Small Cap Research on MSN5d
FBLG: Poster Presentation Shows Potential for Fibroblast Therapy in Psoriasis…
FBLG READ THE FULL FBLG RESEARCH REPORT Business Update Preclinical Psoriasis Data Presented at SID Annual Meeting On May 16, 2025, FibroBiologics, Inc. (NASDAQ:FBLG) announced a poster presentation ...
JNJ Down 6% in 3 Months: How to Play the Stock Amid Various Challenges
Detailed price information for Teva Pharmaceutical Industries ADR (TEVA-N) from The Globe and Mail including charting and ...